INDIA LIVE DESKNIFTY 50:23,140.50(+0.34%)SENSEX:73,895.74(+0.43%)
RDU Global
🇮🇳
Home/Topics/People & Leaders/FDA leadership
Back to Newsroom
👤Key Figure Dossier

FDA leadership

Curated news coverage, institutional background, regulatory filings, and investigative reporting across RDU Global.

6 Stories Indexed
Last Updated: Just Now
Verified Entity Intelligence
Global Health & Biotech 15 Oct 2026, 08:50 AM IST

FDA Moves to Tighten Rare-Disease Drug Reviews as New Leadership Seeks Consistency

The U.S. Food and Drug Administration is preparing a broad reset of how rare-disease medicines are evaluated, with new leadership signaling a push for a more consistent, fit-for-purpose framework that could reshape development standards across the sector. The initiative is likely to affect trial design, evidence expectations and manufacturing oversight, with implications for biotech valuations and the pace of future approvals.

By RDU Global Wire5 min read
Global Markets & Equities15 Oct 2026, 02:39 PM IST

FDA Moves to Tighten Rare-Disease Drug Reviews as New Leadership Seeks Consistency

The U.S. Food and Drug Administration is advancing a new rare-disease framework that could reshape how experimental treatments are designed, reviewed and approved. The initiative signals a shift toward greater consistency and broader evidentiary standards, a move that may raise the bar for developers while potentially improving regulatory predictability.

6 min readRead →
Markets, IPOs & Wealth15 Oct 2026, 12:36 PM IST

Asian Paints Shares Track Cautious Trade as Investors Weigh Demand, Margins and Market Leadership

Asian Paints shares are in focus in midday trade as investors reassess the paint major’s near-term growth trajectory against a mixed demand backdrop and persistent margin pressures. The stock’s movement is being watched closely for signals on consumer demand, pricing discipline and the broader outlook for India’s discretionary spending cycle.

5 min readRead →
Banking, Fintech & Insurance15 Oct 2026, 03:21 AM IST

HDFC Bank Names ICICI Veteran Anup Bagchi as CEO in Leadership Reset

HDFC Bank has appointed Anup Bagchi as its next managing director and chief executive officer, with the Reserve Bank of India approving the move ahead of his October 27, 2026 start date. Bagchi, a seasoned banker with deep experience across retail, corporate and investment banking, returns to the sector after a three-year stint at ICICI Prudential Life Insurance.

5 min readRead →
Clean Energy & Climate Transition14 Oct 2026, 04:51 PM IST

NASA Reassigns Astronaut Christina Koch to Engineering Leadership, Ending Future Flight Status

NASA astronaut Christina Koch, one of the agency’s most accomplished and longest-serving female spacefarers, is moving into a senior engineering leadership role that will end her eligibility for future flight assignments. The transition marks a significant career shift for Koch and underscores NASA’s effort to retain elite astronaut expertise inside the agency as it advances Artemis and other deep-space programs.

6 min readRead →
World Politics & Diplomacy14 Oct 2026, 12:20 AM IST

CBS Leadership Clash With '60 Minutes' Veteran Exposes Deeper Tensions Over Editorial Direction

A reported confrontation between CBS News leadership and veteran '60 Minutes' correspondent Lesley Stahl has intensified scrutiny of the network’s editorial direction under Bari Weiss, the former opinion editor whose influence at CBS has drawn attention from across the media industry. According to multiple reports, Stahl considered quitting after a dispute over a segment involving Israeli settlers, underscoring the sensitivities surrounding coverage of the Israel-Palestine conflict and the broader pressure on legacy newsrooms to navigate polarizing political terrain.

7 min readRead →

👤 About this Entity

Political leaders, ministers, corporate executives, judges, athletes and creators. All news mentioning this entity is automatically verified and aggregated into this live intelligence dossier.

Co-Occurring Entities

Entities frequently referenced alongside FDA leadership: